Non-ST segment elevation acute coronary syndrome (NSTEACS) is the most frequent manifestation of acute coronary syndromes (ACS) [1, 2]. Acute heart failure (HF) remains a common complication of ACS, and it is one of the most important clinical manifestations of worse prognosis. Although improvements in the management of ACS over the last decade have demonstrated a reduction of in-hospital mortality and long-term events, HF is still a prevalent complication and is associated with higher mortality [3–9], being women more likely to develop symptoms of HF in such a clinical setting [3,9].
